Antidepressants/olanzapine/typical antipsychotics

Antidepressants/olanzapine/typical antipsychotics Reactions 1680, p36 - 2 Dec 2017 Antidepressants/olanzapine/typical antipsychotics Lipid derangement, weight gain and dyskinesia: case report A female patient [exact age not stated] developed lipid derangement, weight gain and dyskinesia following treatment with antidepressants, typical antipsychotics [specific drugs not stated] and olanzapine [routes and dosages not stated]. The female, who had a history of treatment resistant psychosis, presented to the hospital with hallucinations and suicidal ideations. During hospitalisation, psychosis persisted despite treatment with several antidepressants, olanzapine and typical antipsychotics. She also received inpatient milieu therapy. Her symptoms did not improve on the treatment. However, she developed lipid derangement, dyskinesia and weight gain, which were considered to be related to the drugs administered [time to reactions onset and outcomes not stated]. Olanzapine serum level was found to be supra therapeutic. Author comment: "Throughout hospitalization, patient continued to be psychotic in spite of treatment with several typical and atypical antipsychotics, antidepressants and inpatient milieu therapy. Interestingly, while her symptoms did not ameliorate in response to medications, she did develop side effects associated with the drugs given, including lipid derangement, weight gain and development of dyskinesia." Etwaroo NR, et al. Refractory psychosis in a patient with mega cisterna magna. CNS Spectrums 21: 115-116, No. 1, Feb 2016. Available from: URL: http:// doi.org/10.1017/S1092852915000905 [abstract] - USA 803284871 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Antidepressants/olanzapine/typical antipsychotics

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/antidepressants-olanzapine-typical-antipsychotics-oPIMvoE8vE
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-38967-3
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p36 - 2 Dec 2017 Antidepressants/olanzapine/typical antipsychotics Lipid derangement, weight gain and dyskinesia: case report A female patient [exact age not stated] developed lipid derangement, weight gain and dyskinesia following treatment with antidepressants, typical antipsychotics [specific drugs not stated] and olanzapine [routes and dosages not stated]. The female, who had a history of treatment resistant psychosis, presented to the hospital with hallucinations and suicidal ideations. During hospitalisation, psychosis persisted despite treatment with several antidepressants, olanzapine and typical antipsychotics. She also received inpatient milieu therapy. Her symptoms did not improve on the treatment. However, she developed lipid derangement, dyskinesia and weight gain, which were considered to be related to the drugs administered [time to reactions onset and outcomes not stated]. Olanzapine serum level was found to be supra therapeutic. Author comment: "Throughout hospitalization, patient continued to be psychotic in spite of treatment with several typical and atypical antipsychotics, antidepressants and inpatient milieu therapy. Interestingly, while her symptoms did not ameliorate in response to medications, she did develop side effects associated with the drugs given, including lipid derangement, weight gain and development of dyskinesia." Etwaroo NR, et al. Refractory psychosis in a patient with mega cisterna magna. CNS Spectrums 21: 115-116, No. 1, Feb 2016. Available from: URL: http:// doi.org/10.1017/S1092852915000905 [abstract] - USA 803284871 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial